Timing of RT With Immunotherapy in Metastatic NSCLC

Radiotherapy followed by immunotherapy within 1–12 months ― but not sooner or later ― may boost progression-free survival in patients with metastatic non–small cell lung cancer, suggests new study.
MDedge News

source https://www.medscape.com/viewarticle/990622?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?